Clinical Trial Update: Autologous Bone Marrow-Derived Stem Cell Therapy for Motor Neuron Disease [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial update on autologous bone marrow-derived stem cell therapy for motor neuron disease, including ALS and related conditions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis
• Lateral Sclerosis
• Motor Neuron Disease
• Progressive Bulbar Palsy
• Progressive Muscular Atrophy

Drugs mentioned

• Autologous bone marrow-derived stem cell therapy

Snippet

Sponsor: Stem Cells Arabia | Conditions: Motor Neuron Disease, Amyotrophic Lateral Sclerosis | Phase 1, Phase 2 | Status: UNKNOWN